Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 310 | 140 | 691 | 14,500 | 557 |
| Cost of Goods | 548 | 142 | 429 | 886 | 338 |
| Gross Profit | -238 | -2 | 262 | 13,614 | 219 |
| Operating Expenses | 4,114 | 3,234 | 3,754 | 4,474 | 3,270 |
| Operating Income | -3,804 | -3,094 | -3,063 | 10,026 | -2,713 |
| Interest Expense | 0 | 0 | 0 | -98 | 0 |
| Other Income | 32 | 17 | 25 | 0 | -192 |
| Pre-tax Income | -3,772 | -3,077 | -3,038 | 10,124 | -2,905 |
| Net Income Continuous | -3,772 | -3,077 | -3,038 | 10,124 | -2,905 |
| Net Income | $-3,772 | $-3,077 | $-3,038 | $10,124 | $-2,905 |
| EPS Basic Total Ops | -0.59 | -0.29 | -0.30 | 1.20 | -0.39 |
| EPS Basic Continuous Ops | -0.59 | -0.29 | -0.30 | 1.20 | -0.42 |
| EPS Diluted Total Ops | -0.27 | -0.29 | -0.30 | 0.88 | -0.42 |
| EPS Diluted Continuous Ops | -0.27 | -0.29 | -0.30 | 0.88 | -0.39 |
| EBITDA(a) | $-3,580 | $-2,897 | $-2,884 | $10,199 | $-2,547 |